Medicine and Dentistry
Adaptation
12%
Age
22%
Alcohol
25%
Analysis
17%
Assessment
18%
Association
22%
Atrophy
12%
Biological Marker
12%
Breast Cancer
12%
Cancer Diagnosis
14%
Cancer Risk
37%
Cancer Survival
25%
Cancer Therapy
12%
Case-Control Study
39%
Cohort Analysis
65%
Cohort Study
14%
COVID-19
38%
Diagnosis
18%
Disease Exacerbation
12%
Drug Therapy
28%
Endoscopy
12%
Esophageal Adenocarcinoma
27%
Esophageal Cancer
81%
Esophageal Cancer
21%
Furosemide
12%
Hazard Ratio
27%
Human Study
12%
Inflammatory Bowel Disease
26%
Inpatient
31%
Intestinal Metaplasia
12%
Lifestyle
13%
Malignant Neoplasm
25%
Man
12%
Mortality
18%
Odds Ratio
19%
Pancreas Cancer
12%
Patient
100%
Prostaglandin Endoperoxide
12%
Smoking
26%
Statin
16%
Stomach Cancer
46%
Stress
19%
Stress Reduction
12%
Survival
26%
Systematic Review
25%
Therapeutic Procedure
31%
UK Biobank
17%
Ulcerative Colitis
12%
Upper Gastrointestinal Cancer
12%
Woman
14%
Nursing and Health Professions
Alcohol
25%
Analysis
14%
Angiotensin Receptor Antagonist
12%
Biobank
15%
Biological Marker
12%
Bisphosphonic Acid Derivative
9%
Breast Cancer
12%
Cancer Risk
19%
Cancer Survival
12%
Cohort Analysis
25%
Confidence Interval
17%
Diagnosis
6%
Diseases
8%
Drug Therapy
14%
Esophageal Adenocarcinoma
29%
Esophagus Cancer
44%
Finasteride
7%
Follow up
5%
Hazard Ratio
16%
Health Care Personnel
16%
Healthcare Profession
12%
Inflammation
12%
Inflammatory Bowel Disease
12%
Inpatient
6%
Malignant Neoplasm
6%
Medical Student
12%
Neoadjuvant Chemotherapy
12%
Neoplasm
6%
Older People
12%
Procedures
12%
Prospective Cohort Study
13%
Researcher
12%
Resuscitation
6%
Spironolactone
7%
Stomach Cancer
17%
Student
19%
Sugar
12%
Surgery
10%
Survival
12%
Tetracycline
7%
Time
27%
Videorecording
12%
Pharmacology, Toxicology and Pharmaceutical Science
Angiotensin Receptor Antagonist
12%
Bisphosphonic Acid Derivative
9%
Cancer Risk
26%
Cancer Survival
12%
Chemotherapy
12%
Cohort Study
25%
Comorbidity
5%
Death
8%
Esophageal Adenocarcinoma
12%
Esophagus Cancer
64%
Finasteride
7%
Furosemide
12%
Inflammation
12%
Malignant Neoplasm
33%
Mortality
24%
Oxidoreductase
12%
Prostaglandin Endoperoxide
12%
Spironolactone
7%
Statin (Protein)
29%
Stomach Cancer
33%
Survival
51%
Tetracycline
7%